BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide ROKU Q1 2026 Earnings EPS Surges Past Estimates with 71 Beat BN Q1 2026 Earnings Slight EPS Beat Amid Resilient Asset Management Performance Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported TFPM Q1 2026 Earnings EPS Surpasses Estimates as Royalty Performance Drives Results Enerpac Tool Group EPAC Holds Steady Near 3458 as Consolidation Continues XCF Global SAFX Edges Lower as Stock Tests Key Support Levels LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Fortive FTV Shows Modest Decline Amid Consolidation Range SNYR Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure